Tan T, Wu C, Wang R, Pan B, Hawke D, Yin F
iScience. 2025; 28(1):111603.
PMID: 39834856
PMC: 11743101.
DOI: 10.1016/j.isci.2024.111603.
Kruger S, Pfaff N, Graf R, Meyer I
Cells. 2024; 13(18.
PMID: 39329697
PMC: 11430746.
DOI: 10.3390/cells13181513.
Veraguas-Davila D, Zapata-Rojas C, Aguilera C, Saez-Ruiz D, Saravia F, Castro F
Int J Mol Sci. 2024; 25(8).
PMID: 38673927
PMC: 11050229.
DOI: 10.3390/ijms25084343.
El Dika M, Dudka D, Kloc M, Kubiak J
Biology (Basel). 2023; 12(6).
PMID: 37372141
PMC: 10295169.
DOI: 10.3390/biology12060855.
Wang Q, Bode A, Zhang T
NPJ Precis Oncol. 2023; 7(1):58.
PMID: 37311884
PMC: 10264400.
DOI: 10.1038/s41698-023-00407-7.
Revisiting the multisite phosphorylation that produces the M-phase supershift of key mitotic regulators.
Tan T, Wu C, Liu B, Pan B, Hawke D, Su Z
Mol Biol Cell. 2022; 33(12):ar115.
PMID: 35976701
PMC: 9635296.
DOI: 10.1091/mbc.E22-04-0118.
An updated view on the centrosome as a cell cycle regulator.
Lin M, Xie S, Chan K
Cell Div. 2022; 17(1):1.
PMID: 35164835
PMC: 8842576.
DOI: 10.1186/s13008-022-00077-0.
The intrinsically disorderly story of Ki-67.
Remnant L, Kochanova N, Reid C, Cisneros-Soberanis F, Earnshaw W
Open Biol. 2021; 11(8):210120.
PMID: 34375547
PMC: 8354752.
DOI: 10.1098/rsob.210120.
Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy.
Zhang X, Wei C, Liang H, Han L
Front Oncol. 2021; 11:587554.
PMID: 33777739
PMC: 7994899.
DOI: 10.3389/fonc.2021.587554.
Dissection of the Ovulatory Process Using Approaches.
Tokmakov A, Stefanov V, Sato K
Front Cell Dev Biol. 2020; 8:605379.
PMID: 33363163
PMC: 7755606.
DOI: 10.3389/fcell.2020.605379.
BUB1 and CENP-U, Primed by CDK1, Are the Main PLK1 Kinetochore Receptors in Mitosis.
Singh P, Pesenti M, Maffini S, Carmignani S, Hedtfeld M, Petrovic A
Mol Cell. 2020; 81(1):67-87.e9.
PMID: 33248027
PMC: 7837267.
DOI: 10.1016/j.molcel.2020.10.040.
P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.
Yao D, Li C, Rajoka M, He Z, Huang J, Wang J
Theranostics. 2020; 10(21):9741-9766.
PMID: 32863957
PMC: 7449905.
DOI: 10.7150/thno.46913.
BORA regulates cell proliferation and migration in bladder cancer.
Cheng S, Peng T, Zhu X, Zhou F, Wang G, Ju L
Cancer Cell Int. 2020; 20:290.
PMID: 32655322
PMC: 7339433.
DOI: 10.1186/s12935-020-01392-8.
The G2-to-M transition from a phosphatase perspective: a new vision of the meiotic division.
Lemonnier T, Dupre A, Jessus C
Cell Div. 2020; 15:9.
PMID: 32508972
PMC: 7249327.
DOI: 10.1186/s13008-020-00065-2.
Role of Polo-like kinase 1 in the regulation of the action of p31 in the disassembly of mitotic checkpoint complexes.
Kaisari S, Shomer P, Ziv T, Sitry-Shevah D, Miniowitz-Shemtov S, Teichner A
Proc Natl Acad Sci U S A. 2019; 116(24):11725-11730.
PMID: 31118282
PMC: 6575526.
DOI: 10.1073/pnas.1902970116.
A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening.
Abdelfatah S, Berg A, Bockers M, Efferth T
J Adv Res. 2019; 16:145-156.
PMID: 30899597
PMC: 6412170.
DOI: 10.1016/j.jare.2018.10.002.
Phosphatases in Mitosis: Roles and Regulation.
Moura M, Conde C
Biomolecules. 2019; 9(2).
PMID: 30736436
PMC: 6406801.
DOI: 10.3390/biom9020055.
Multiple Mechanisms Inactivate the LIN-41 RNA-Binding Protein To Ensure a Robust Oocyte-to-Embryo Transition in .
Spike C, Huelgas-Morales G, Tsukamoto T, Greenstein D
Genetics. 2018; 210(3):1011-1037.
PMID: 30206186
PMC: 6218228.
DOI: 10.1534/genetics.118.301421.
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key.
Pintard L, Archambault V
Open Biol. 2018; 8(8).
PMID: 30135239
PMC: 6119860.
DOI: 10.1098/rsob.180114.
Phosphorylation of CDC25C by AMP-activated protein kinase mediates a metabolic checkpoint during cell-cycle G/M-phase transition.
Shen Y, Sherman J, Chen X, Wang R
J Biol Chem. 2018; 293(14):5185-5199.
PMID: 29467227
PMC: 5892595.
DOI: 10.1074/jbc.RA117.001379.